Could other viruses cause pediatric posttransplant lymphoproliferative disorder?

Clinical and Translational Oncology

Volumn 10, Issue 7, 2008, Pages 422-425

  Vila, Leticia ^a   Moreno, Lucas ^a   Andrés, María Del Mar ^a   Fernández, José María ^a   Verdeguer, Amparo ^a   Pérez Valle, Sonia ^a   Sangüesa, Cinta ^a   Berbel, Octavio ^a   Castel, Victoria ^a  

^a HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

ATG; EBV; Lymphoproliferative; PTLD; Stem cell transplant

Indexed keywords

ARTICLE; CASE REPORT; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; HUMAN; INFANT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NEWBORN; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; STEM CELL TRANSPLANTATION; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIRUS DISEASES;

EID: 53749096641     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0225-6     Document Type: Article

References (10)

1. Opelz G, Schwarz V, Wujciak T et al (1995) Analysis of non-Hodgkin's lymphomas in organ transplant recipients. Transplant Rev 9:231-240
2. Dharnidharka VR, Sullivan EK, Stablein DM et al (2001) Risk factors for post transplant lymphoproliferative disorder (PTLD) in kidney transplantation: a report of the North America Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71:1065-1068
3. Collins MH, Montone KT, Leahey AM et al (2001) Post-transplant lymphoproliferative disease in children. Pediatr Transplantation 5:250-257
4. van Esser JW, van der Holt B, Meijer E et al (2001) Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBVlymphoproliferative disease following T-cell depleted SCT. Blood 98(4):972-978
5. Cockfield SM (2001) Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 3:70-80
6. Shapiro R, Nalesnik M, McCauley J et al (1999) Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant recipient receiving tacrolimus based immunosuppression. Transplantation 68:1851-1854
7. Razonable R, Paya C (2003) Herpesvirus infections in transplant recipients: current challenges in the clinical management or Cytomegalovirus and Epstein-Barr virus infections. Herpes 10(3): 60-65
8. Manez R, Breinig MC, Linden P et al (1997) Post-transplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J infect Dis 176:1462-1467
9. Opelz G, Doler B (2003) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Tranplantation 4:222-230
10. Verchuuren EA, Stevens SJ, van Imhoff GW (2007) Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse and the complication. Transplantation 73:100-104